The role of synovitis in osteoarthritis pathogenesis

Bone

Volumn 51, Issue 2, 2012, Pages 249-257

  Scanzello, Carla R ^a   Goldring, Steven R ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Complement; Cytokines; Inflammation; Osteoarthritis; Synovitis; Toll like receptors

Indexed keywords

CHEMOKINE RECEPTOR CCR7; COLLAGENASE 3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5A; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 8; LUBRICIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MATRIX METALLOPROTEINASE; RANTES; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CARTILAGE CELL; CELL ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PATHOGENESIS; PATHOLOGICAL ANATOMY; REVIEW; SYMPTOMATOLOGY; SYNOVITIS; SYNOVIUM; ULTRASOUND; X RAY;

ANIMALS; DISEASE PROGRESSION; HUMANS; INFLAMMATION MEDIATORS; OSTEOARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; SYNOVITIS;

EID: 84861983196     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.02.012     Document Type: Review

References (112)

1. Abdollahi-Roodsaz S., Joosten L.A., Koenders M.I., Devesa I., Roelofs M.F., Radstake T.R., et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008, 118:205-216.
2. Akira S., Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004, 4:499-511.
3. Ayral X., Pickering E.H., Woodworth T.G., Mackillop N., Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis - results of a 1year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 2005, 13:361-367.
4. Baker K., Grainger A., Niu J., Clancy M., Guermazi A., Crema M., et al. Relation of synovitis to knee pain using contrast-enhanced MRIs. Ann Rheum Dis 2010, 69:1779-1783.
5. Barker S.A., Bayyuk S.H., Brimacombe J.S., Hawkins C.F., Stacey M. Fingerprinting the hyaluronic acid component of normal and pathological synovial fluids. Clin Chim Acta 1963, 8:902-909.
6. Belcher C., Yaqub R., Fawthrop F., Bayliss M., Doherty M. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees. Ann Rheum Dis 1997, 56:299-307.
7. Benito M.J., Veale D.J., FitzGerald O., van den Berg W.B., Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005, 64:1263-1267.
8. Blom A.B., van Lent P.L., Libregts S., Holthuysen A.E., van der Kraan P.M., van Rooijen N., et al. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 2007, 56:147-157.
9. Bock H.C., Michaeli P., Bode C., Schultz W., Kresse H., Herken R., et al. The small proteoglycans decorin and biglycan in human articular cartilage of late-stage osteoarthritis. Osteoarthritis Cartilage 2001, 9:654-663.
10. Bondeson J., Blom A.B., Wainwright S., Hughes C., Caterson B., van den Berg W.B. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum 2010, 62:647-657.
11. Borzi R.M., Mazzetti I., Cattini L., Uguccioni M., Baggiolini M., Facchini A. Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum 2000, 43:1734-1741.
12. Bradley K., North J., Saunders D., Schwaeble W., Jeziorska M., Woolley D.E., et al. Synthesis of classical pathway complement components by chondrocytes. Immunology 1996, 88:648-656.
13. Bresnihan B., Flanagan A.M. Synovium. Kelley's textbook of rheumatology I 2009, 23-36. Saunders Elsevier. G.S. Firestein, R.C. Budd, E.D.J. Harris, I.B. McInnes, S. Ruddy, J.S. Sergent (Eds.).
14. Bruhl H., Mack M., Niedermeier M., Lochbaum D., Scholmerich J., Straub R.H. Functional expression of the chemokine receptor CCR7 on fibroblast-like synoviocytes. Rheumatology (Oxford) 2008, 47:1771-1774.
15. Cantatore F.P., Benazzo F., Ribatti D., Lapadula G., D'Amico S., Tursi A., et al. Early alteration of synovial membrane in osteoarthrosis. Clin Rheumatol 1988, 7:214-219.
16. Carrion M., Juarranz Y., Perez-Garcia S., Jimeno R., Pablos J.L., Gomariz R.P., et al. RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: immune regulation by vasoactive intestinal peptide. Arthritis Rheum 2011, 63:1626-1636.
17. Chevalier X., Claudepierre P., Groult N., Zardi L., Hornebeck W. Presence of ED-A containing fibronectin in human articular cartilage from patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 1996, 23:1022-1030.
18. Chevalier X., Giraudeau B., Conrozier T., Marliere J., Kiefer P., Goupille P. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study. J Rheumatol 2005, 32:1317-1323.
19. Chevalier X., Groult N., Larget-Piet B., Zardi L., Hornebeck W. Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1994, 37:1013-1022.
20. Cohen S.B., Proudman S., Kivitz A.J., Burch F.X., Donohue J.P., Burstein D., et al. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL 1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther 2011, 13:R125.
21. Conaghan P.G., D'Agostino M.A., Le Bars M., Baron G., Schmidely N., Wakefield R., et al. Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study. Ann Rheum Dis 2010, 69:644-647.
22. Crawford A., Frazer A., Lippitt J.M., Buttle D.J., Smith T. A case of chondromatosis indicates a synovial stem cell aetiology. Rheumatology (Oxford) 2006, 45:1529-1533.
23. Cs-Szabo G., Roughley P.J., Plaas A.H., Glant T.T. Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage. Arthritis Rheum 1995, 38:660-668.
24. Cuellar J.M., Scuderi G.J., Cuellar V.G., Golish S.R., Yeomans D.C. Diagnostic utility of cytokine biomarkers in the evaluation of acute knee pain. J Bone Joint Surg Am 2009, 91:2313-2320.
25. Dahl L.B., Dahl I.M., Engstrom-Laurent A., Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985, 44:817-822.
26. Dingle J.T., Saklatvala J., Hembry R., Tyler J., Fell H.B., Jubb R. A cartilage catabolic factor from synovium. Biochem J 1979, 184:177-180.
27. Ehrnthaller C., Ignatius A., Gebhard F., Huber-Lang M. New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med 2011, 17:317-329.
28. Endres M., Andreas K., Kalwitz G., Freymann U., Neumann K., Ringe J., et al. Chemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal progenitor cells. Osteoarthritis Cartilage 2010, 18:1458-1466.
29. Fan J., Varshney R.R., Ren L., Cai D., Wang D.A. Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. Tissue Eng Part B Rev 2009, 15:75-86.
30. Fernandez-Madrid F., Karvonen R.L., Teitge R.A., Miller P.R., An T., Negendank W.G. Synovial thickening detected by MR imaging in osteoarthritis of the knee confirmed by biopsy as synovitis. Magn Reson Imaging 1995, 13:177-183.
31. Fotinos-Hoyer A.K., Guermazi A., Jara H., Eckstein F., Ozonoff A., Khard H., et al. Assessment of synovitis in the osteoarthritic knee: comparison between manual segmentation, semiautomated segmentation, and semiquantitative assessment using contrast-enhanced fat-suppressed T1-weighted MRI. Magn Reson Med 2010, 64:604-609.
32. Fox D.B., Warnock J.J. Cell-based meniscal tissue engineering: a case for synoviocytes. Clin Orthop Relat Res 2011.
33. Fujikawa Y., Shingu M., Torisu T., Masumi S. Interleukin-1 receptor antagonist production in cultured synovial cells from patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1995, 54:318-320.
34. Gobezie R., Kho A., Krastins B., Sarracino D.A., Thornhill T.S., Chase M., et al. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther 2007, 9:R36.
35. Goldberg R.L., Huff J.P., Lenz M.E., Glickman P., Katz R., Thonar E.J. Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1991, 34:799-807.
36. Goldenberg D.L., Egan M.S., Cohen A.S. Inflammatory synovitis in degenerative joint disease. J Rheumatol 1982, 9:204-209.
37. Goldring M.B., Birkhead J., Sandell L.J., Kimura T., Krane S.M. Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest 1988, 82:2026-2037.
38. Goldring M.B., Otero M., Plumb D.A., Dragomir C., Favero M., El Hachem K., et al. Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur Cell Mater 2011, 21:202-220.
39. Guermazi A., Roemer F.W., Hayashi D., Crema M.D., Niu J., Zhang Y., et al. Assessment of synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in people with, or at high risk of, knee osteoarthritis: the MOST study. Ann Rheum Dis 2011, 70:805-811.
40. Happonen K.E., Saxne T., Aspberg A., Morgelin M., Heinegard D., Blom A.M. Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum 2010, 62:3574-3583.
41. Haringman J.J., Smeets T.J., Reinders-Blankert P., Tak P.P. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis 2006, 65:294-300.
42. Heiland G.R., Aigner E., Dallos T., Sahinbegovic E., Krenn V., Thaler C., et al. Synovial immunopathology in haemochromatosis arthropathy. Ann Rheum Dis 2010, 69:1214-1219.
43. Hill C.L., Hunter D.J., Niu J., Clancy M., Guermazi A., Genant H., et al. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis 2007, 66:1599-1603.
44. Hui A.Y., McCarty W.J., Masuda K., Firestein G.S., Sah R.L. A systems biology approach to synovial joint lubrication in health, injury, and disease. Wiley Interdiscip Rev Syst Biol Med 2011, 4:15-37.
45. Hunter D.J., Lo G.H., Gale D., Grainger A.J., Guermazi A., Conaghan P.G. The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston Leeds Osteoarthritis Knee Score). Ann Rheum Dis 2008, 67:206-211.
46. Ishijima M., Watari T., Naito K., Kaneko H., Futami I., Yoshimura-Ishida K., et al. Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis. Arthritis Res Ther 2011, 13:R22.
47. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
48. Jin C., Frayssinet P., Pelker R., Cwirka D., Hu B., Vignery A., et al. NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy. Proc Natl Acad Sci U S A 2011.
49. Jung Y.O., Cho M.L., Kang C.M., Jhun J.Y., Park J.S., Oh H.J., et al. Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts. Immunol Lett 2007, 109:21-27.
50. Kalchishkova N., Furst C.M., Heinegard D., Blom A.M. NC4 domain of cartilage-specific collagen IX inhibits complement directly due to attenuation of membrane attack formation and indirectly through binding and enhancing activity of complement inhibitors C4B-binding protein and factor H. J Biol Chem 2011, 286:27915-27926.
51. Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J.P., Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011, 7:33-42.
52. Kim H.A., Cho M.L., Choi H.Y., Yoon C.S., Jhun J.Y., Oh H.J., et al. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum 2006, 54:2152-2163.
53. Kokebie R., Aggarwal R., Lidder S., Hakimiyan A.A., Rueger D.C., Block J.A., et al. The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors. Arthritis Res Ther 2011, 13:R50.
54. Konttinen Y.T., Ceponis A., Meri S., Vuorikoski A., Kortekangas P., Sorsa T., et al. Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane. Ann Rheum Dis 1996, 55:888-894.
55. Krasnokutsky S., Belitskaya-Levy I., Bencardino J., Samuels J., Attur M., Regatte R., et al. Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritis. Arthritis Rheum 2011, 63:2983-2991.
56. Krenn V., Morawietz L., Burmester G.R., Kinne R.W., Mueller-Ladner U., Muller B., et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 2006, 49:358-364.
57. Krenn V., Morawietz L., Haupl T., Neidel J., Petersen I., Konig A. Grading of chronic synovitis - a histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract 2002, 198:317-325.
58. Kyburz D., Rethage J., Seibl R., Lauener R., Gay R.E., Carson D.A., et al. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by Toll-like receptor signaling. Arthritis Rheum 2003, 48:642-650.
59. Lasarte J.J., Casares N., Gorraiz M., Hervas-Stubbs S., Arribillaga L., Mansilla C., et al. The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo. J Immunol 2007, 178:748-756.
60. Lawrence R.C., Felson D.T., Helmick C.G., Arnold L.M., Choi H., Deyo R.A., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008, 58:26-35.
61. Lindblad S., Hedfors E. Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis. Arthritis Rheum 1987, 30:1081-1088.
62. Ling S.M., Patel D.D., Garnero P., Zhan M., Vaduganathan M., Muller D., et al. Serum protein signatures detect early radiographic osteoarthritis. Osteoarthritis Cartilage 2009, 17:43-48.
63. Liu-Bryan R., Terkeltaub R. Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice. Arthritis Rheum 2010, 62:2004-2012.
64. Liu L., Ishijima M., Futami I., Kaneko H., Kubota M., Kawasaki T., et al. Correlation between synovitis detected on enhanced-magnetic resonance imaging and a histological analysis with a patient-oriented outcome measure for Japanese patients with end-stage knee osteoarthritis receiving joint replacement surgery. Clin Rheumatol 2010, 29:1185-1190.
65. Loeuille D., Chary-Valckenaere I., Champigneulle J., Rat A.C., Toussaint F., Pinzano-Watrin A., et al. Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity. Arthritis Rheum 2005, 52:3492-3501.
66. Long D., Blake S., Song X.Y., Lark M., Loeser R.F. Human articular chondrocytes produce IL-7 and respond to IL-7 with increased production of matrix metalloproteinase-13. Arthritis Res Ther 2008, 10:R23.
67. Magnano M.D., Chakravarty E.F., Broudy C., Chung L., Kelman A., Hillygus J., et al. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. J Rheumatol 2007, 34:1323-1327.
68. Marcu K.B., Otero M., Olivotto E., Borzi R.M., Goldring M.B. NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets 2010, 11:599-613.
69. Martinon F., Petrilli V., Mayor A., Tardivel A., Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
70. Mazieres B., Garnero P., Gueguen A., Abbal M., Berdah L., Lequesne M., et al. Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis 2006, 65:354-359.
71. Mengshol J.A., Vincenti M.P., Coon C.I., Barchowsky A., Brinckerhoff C.E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 2000, 43:801-811.
72. Midwood K., Sacre S., Piccinini A.M., Inglis J., Trebaul A., Chan E., et al. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 2009, 15:774-780.
73. Oehler S., Neureiter D., Meyer-Scholten C., Aigner T. Subtyping of osteoarthritic synoviopathy. Clin Exp Rheumatol 2002, 20:633-640.
74. Ospelt C., Brentano F., Rengel Y., Stanczyk J., Kolling C., Tak P.P., et al. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum 2008, 58:3684-3692.
75. Ozawa T., Koyama K., Ando T., Ohnuma Y., Hatsushika K., Ohba T., et al. Thymic stromal lymphopoietin secretion of synovial fibroblasts is positively and negatively regulated by Toll-like receptors/nuclear factor-kappaB pathway and interferon-gamma/dexamethasone. Mod Rheumatol 2007, 17:459-463.
76. Pazar B., Ea H.K., Narayan S., Kolly L., Bagnoud N., Chobaz V., et al. Basic calcium phosphate crystals induce monocyte/macrophage IL-1beta secretion through the NLRP3 inflammasome in vitro. J Immunol 2011, 186:2495-2502.
77. Pessler F., Dai L., Diaz-Torne D., Gomez-Vaquero C., Paessler M.E., Zheng D.H., et al. The synovitis of "non-inflammatory" orthopedic arthropathies: a quantitative histologic and immunohistochemical analysis. Ann Rheum Dis 2008, 67:1184-1187.
78. Peterfy C.G., Guermazi A., Zaim S., Tirman P.F., Miaux Y., White D., et al. Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage 2004, 12:177-190.
79. Piccinini A.M., Midwood K.S. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010, [Electronic publication ahead of print 2010 Jul 13]. 10.1155/2010/672395.
80. Poole A.R., Rosenberg L.C., Reiner A., Ionescu M., Bogoch E., Roughley P.J. Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage. J Orthop Res 1996, 14:681-689.
81. Revell P.A., Mayston V., Lalor P., Mapp P. The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies. Ann Rheum Dis 1988, 47:300-307.
82. Rhee D.K., Marcelino J., Baker M., Gong Y., Smits P., Lefebvre V., et al. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest 2005, 115:622-631.
83. Richardson D.W., Dodge G.R. Effects of interleukin-1beta and tumor necrosis factor-alpha on expression of matrix-related genes by cultured equine articular chondrocytes. Am J Vet Res 2000, 61:624-630.
84. Roemer F.W., Guermazi A., Felson D.T., Niu J., Nevitt M.C., Crema M.D., et al. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann Rheum Dis 2011, 70:1804-1809.
85. Roemer F.W., Kassim Javaid M., Guermazi A., Thomas M., Kiran A., Keen R., et al. Anatomical distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on non-enhanced and contrast-enhanced MRI. Osteoarthritis Cartilage 2010, 18:1269-1274.
86. Rosenthal A.K., Gohr C.M., Ninomiya J., Wakim B.T. Proteomic analysis of articular cartilage vesicles from normal and osteoarthritic cartilage. Arthritis Rheum 2011, 63:401-411.
87. Scanzello C.R., McKeon B., Swaim B.H., DiCarlo E., Asomugha E.U., Kanda V., et al. Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. Arthritis Rheum 2011, 63:391-400.
88. Scanzello C.R., Plaas A., Crow M.K. Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound?. Curr Opin Rheumatol 2008, 20:565-572.
89. Scanzello C.R., Umoh E., Pessler F., Diaz-Torne C., Miles T., Dicarlo E., et al. Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthritis Cartilage 2009, 17:1040-1048.
90. Schaefer L., Babelova A., Kiss E., Hausser H.J., Baliova M., Krzyzankova M., et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 2005, 115:2223-2233.
91. Scheibner K.A., Lutz M.A., Boodoo S., Fenton M.J., Powell J.D., Horton M.R. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006, 177:1272-1281.
92. Schlaak J.F., Pfers I., Meyer Zum Buschenfelde K.H., Marker-Hermann E. Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin Exp Rheumatol 1996, 14:155-162.
93. Sellam J., Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010, 6:625-635.
94. Shen P.C., Wu C.L., Jou I.M., Lee C.H., Juan H.Y., Lee P.J., et al. T helper cells promote disease progression of osteoarthritis by inducing macrophage inflammatory protein-1gamma. Osteoarthritis Cartilage 2011, 19:728-736.
95. Sjoberg A., Onnerfjord P., Morgelin M., Heinegard D., Blom A.M. The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem 2005, 280:32301-32308.
96. Sjoberg A.P., Manderson G.A., Morgelin M., Day A.J., Heinegard D., Blom A.M. Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol 2009, 46:830-839.
97. Slansky E., Li J., Haupl T., Morawietz L., Krenn V., Pessler F. Quantitative determination of the diagnostic accuracy of the synovitis score and its components. Histopathology 2010, 57:436-443.
98. Sohn D.H., Sokolove J., Sharpe O., Erhart J.C., Chandra P.E., Lahey L.J., et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res Ther 2012, 14(1):R798.
99. Song I.H., Althoff C.E., Hermann K.G., Scheel A.K., Knetsch T., Burmester G.R., et al. Contrast-enhanced ultrasound in monitoring the efficacy of a bradykinin receptor 2 antagonist in painful knee osteoarthritis compared with MRI. Ann Rheum Dis 2009, 68:75-83.
100. Sowers M., Karvonen-Gutierrez C.A., Jacobson J.A., Jiang Y., Yosef M. Associations of anatomical measures from MRI with radiographically defined knee osteoarthritis score, pain, and physical functioning. J Bone Joint Surg Am 2011, 93:241-251.
101. Stafford C.T., Niedermeier W., Holley H.L., Pigman W. Studies on the Concentration and Intrinsic Viscosity of Hyaluronic Acid in Synovial Fluids of Patients with Rheumatic Diseases. Ann Rheum Dis 1964, 23:152-157.
102. Su S.L., Yang H.Y., Lee C.H., Huang G.S., Salter D.M., Lee H.S. The (-1486T/C) promoter polymorphism of the TLR-9 gene is associated with end-stage knee osteoarthritis in a Chinese population. J Orthop Res 2012, 30:9-14.
103. Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol 2005, 17:1-14.
104. Tamaki Y., Takakubo Y., Hirayama T., Konttinen Y.T., Goodman S.B., Yamakawa M., et al. Expression of Toll-like receptors and their signaling pathways in rheumatoid synovitis. J Rheumatol 2011, 38:810-820.
105. Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., Gallo R.L. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004, 279:17079-17084.
106. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002, 195:99-111.
107. Torres L., Dunlop D.D., Peterfy C., Guermazi A., Prasad P., Hayes K.W., et al. The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis. Osteoarthritis Cartilage 2006, 14:1033-1040.
108. Tortorella M.D., Burn T.C., Pratta M.A., Abbaszade I., Hollis J.M., Liu R., et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999, 284:1664-1666.
109. van Lent P.L., Blom A.B., van der Kraan P., Holthuysen A.E., Vitters E., van Rooijen N., et al. Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum 2004, 50:103-111.
110. Walsh D.A., Bonnet C.S., Turner E.L., Wilson D., Situ M., McWilliams D.F. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage 2007, 15:743-751.
111. Wang Q., Rozelle A., Lepus C., Scanzello C., Song J., Larsen D., et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011, 17:1674-1679.
112. Yang Z., Schmitt J.F., Lee E.H. Immunohistochemical analysis of human mesenchymal stem cells differentiating into chondrogenic, osteogenic, and adipogenic lineages. Methods Mol Biol 2011, 698:353-366.